Allspring Global Investments’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.4M Buy
200,257
+10,644
+6% +$1.83M 0.06% 380
2025
Q1
$28.7M Buy
189,613
+36,875
+24% +$5.58M 0.05% 429
2024
Q4
$21.1M Sell
152,738
-8,672
-5% -$1.2M 0.03% 520
2024
Q3
$24.1M Sell
161,410
-17,842
-10% -$2.66M 0.04% 510
2024
Q2
$24.4M Sell
179,252
-9,956
-5% -$1.36M 0.04% 499
2024
Q1
$28.6M Sell
189,208
-13,964
-7% -$2.11M 0.04% 475
2023
Q4
$25.6M Sell
203,172
-9,823
-5% -$1.24M 0.04% 491
2023
Q3
$19.9M Sell
212,995
-11,524
-5% -$1.08M 0.04% 556
2023
Q2
$20M Sell
224,519
-15,696
-7% -$1.4M 0.03% 597
2023
Q1
$25.8M Sell
240,215
-10,355
-4% -$1.11M 0.04% 510
2022
Q4
$30.6M Sell
250,570
-5,358
-2% -$654K 0.05% 453
2022
Q3
$26.4M Sell
255,928
-7,781
-3% -$803K 0.05% 487
2022
Q2
$24.5M Sell
263,709
-4,886
-2% -$454K 0.04% 519
2022
Q1
$31.5M Sell
268,595
-7,358
-3% -$863K 0.04% 517
2021
Q4
$37.1M Buy
+275,953
New +$37.1M 0.04% 526